论文部分内容阅读
目的 通过回顾性分析,研究壮肾固精方治疗血尿为主IgA肾病临床疗效.方法 根据患者是否使用壮肾固精方分为治疗组(壮肾固精方组)和对照组(一般治疗组)(各19例),通过搜集病例的临床资料,记录并计算其治疗前后的尿红细胞计数,得出两组治疗方法的临床疗效差异.结果 总有效率治疗组为73.68％,对照组为52.63％,两组疗效对比,差别有统计学意义(P＜0.05).结论 壮肾固精方在治疗IgA肾病血尿方面有较好疗效.“,”Objective:To study the clinical efficacy of the treatment of IgA nepropathy whose main symptom is hematuria with the prescription of Zhuangshen Gujing.Methods:According to whether the patients with the prescription of Zhuangshen Gujing,they that meet the inclusion criteria were divided into treatment group and control group.The clinical data of cases were collected,and we calculate and record theurine red blood cell count of patients before and after treatment.we find out the differences of the clinical efficacy of treatment methods of the two group by this.Results:The complete remission rate in the treatment group were73.68％,while in the control group,it was 52.63％.Comparison of the two groups shows that the difference is statistically significant,P＜0.05.Conclusion:The prescription of Zhuangshen Gujing has a better therapeutic effect on the hematuria in treating IgA nephropathy.